Accelerated Pharma's Debt - III Round

Accelerated Pharma raised a round of funding on May 04, 2016.

Accelerated Pharma is a late-stage biotech com­pany in cancer drug development, focused on in-licensing late-stage drug programs that were halted by their developers because of non-critical issues, s…

Articles about Accelerated Pharma's Debt - III Round: